Twitxy
Saved
@RodlerSeverin's profile picture
View on X

Severin Rodler

@RodlerSeverin

AI Research Fellow at USC | Assistant Professor at LMU Munich | Uroletics - the prostate cancer app.
Los Angeles Joined December 2019
361 Following 182 Followers 201 Posts

Latest posts 5

Severin Rodler @RodlerSeverin
📢Final call from the @EAU_YAUroTech group!

We’re mapping the #AI maturity of urologic centers — and we need your input!

👫Open to all urologists
⏰ Only 8 minutes to complete

Help shape the future of AI in urology 👇 surveymonkey.com/r/RR93FTP
www.surveymonkey.com Assessing the Maturity of European Centres for AI-Enabled Robotic Surgery Take this survey powered by surveymonkey.com. Create your own surveys for free.
Severin Rodler @RodlerSeverin
Very important study to show the real value of #LLM in patient education.

Thank you to @Cacciamani_MD, the team of @USC_Urology and the @Urology_AI for making this possible.

Great to see a collaboration across different groups of the @EAUYAUrology working on this topic!
Dr. Giovanni E Cacciamani MD MSc FEBU 🇮🇹🇺🇸🇪🇺 Verified account @Cacciamani_MD Jun 7, 2025
🧠 Can AI Improve Patient Education?

Our new study finds that GPT-4 can craft easy-to-read patient education materials that adhere to cancer guidelines with high accuracy and clarity

📚 Improved Readability - GPT-4 PEMs scored better (FKRE: 70.8) than originals (FKRE: 43.5)
🔍 Accurate & Clear - AI PEMs match originals in accuracy and clarity
🌐 Multilingual Success - Translations are mostly faithful (77.5%) and clear (67.5%)

>> tnyp.me/vboCbx8Q/x

@RodlerSeverin @ConnerGanjavi @EnricoCheccucci @GGandaglia @UroMoschini @Ric_Campi @LoicBaekelandt @PuliattiStefano @alessandroveccia @KFKowalewski @CDFankhauser @marktaratkin @pidebacker @JGomezRivas @inesrivbel @GiorgioI_Russo @andrea_cocci @Uroweb @PLOSONE
#AI #Healthcare #PatientEducation #Pub2Post
View quoted post on X
Severin Rodler @RodlerSeverin
Important data!🧐

Follow us for more insights from our editorial team of @EurUrolFocus:

@cgratzke @DrDeanElterman @Tilki_De @inman, Brant Inman, @MalteRieken
Eur Urol Focus Verified account @EurUrolFocus Dec 3, 2024
Editor's Choice of the Week: The Highest Grade Group Does Not Drive the Risk of Recurrence when Systematic and MRI-targeted Biopsies are Discordant by @SimoneScuderi, @VickersBiostats et al

Read the full article here: buff.ly/4fS0sv9

#UroSoMe #MedTwitter #EditorsChoice
View quoted post on X
Severin Rodler @RodlerSeverin
IO discontinuation in urothelial carcinoma:
🌟 11 out of 108 patients with severe irAEs to stop ICI therapy.
🩺 Common irAEs: hepatitis (4), pneumonitis (2), and gastritis/colitis (2).
📈 Post-discontinuation: 6 complete remission, 3 partial response.
doi.org/10.3390/cancer…
www.mdpi.com Toxicity-Induced Discontinuation of Immune Checkpoint Inhibitors in Metastatic Urothelial Cancer:... Immune checkpoint inhibitor (ICI) therapies have been established as the standard-of-care in various uro-oncological cancers. Immune-related adverse events (irAEs) are frequent, but their degree...
Severin Rodler @RodlerSeverin
Interesting how AI helps in the workflow of prostate biopsies. Great study from @GuenzelKarsten, @Charlie_Charite and team.
Eur Urol Focus Verified account @EurUrolFocus Jun 2, 2024
@GuenzelKarsten on the #practical use of AI support for biopsy planing:

🎯CAD increased csPCa detection sensitivity (97% vs 92%, p=0.007).
🔬 CAD detected additional csPCa lesions in 8% of cases.
🔄 Potential change in management?

eu-focus.europeanurology.com/article/S2405-…
View quoted post on X